# Research Alliance Corporation III (RACC)

**Exchange:** NASDAQ  
**Sector:** Financial Services  
**Price:** $10.42 (-0.19%)

> Research Alliance Corporation III is a special purpose acquisition company formed in 2026 and headquartered in New York, New York. The company operates as a blank check entity, established to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operating businesses. Research Alliance Corporation III primarily targets opportunities in healthcare and healthcare-related industries, with a particular emphasis on drug development, health technology, diagnostics, and healthcare services. Its structure allows institutional and individual investors to gain exposure to a private operating company that may ultimately combine with the SPAC. The sponsor and management team draw on experience in life sciences investing and analysis to identify and evaluate potential targets. In the broader financial market, Research Alliance Corporation III serves as an intermediary vehicle, channeling capital from public investors to privately held healthcare and health-tech companies seeking access to public markets and additional funding via a business combination transaction.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/RACC)